| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Rank within Category |
|---|---|---|---|---|---|
| 1 Week | 28-Oct-25 | 9892.40 | -1.08% | - | 14/229 |
| 1 Month | 03-Oct-25 | 9888.60 | -1.11% | - | 207/226 |
| 3 Month | 04-Aug-25 | 10348.50 | 3.48% | - | 92/224 |
| 6 Month | 02-May-25 | 11880.40 | 18.80% | - | 10/213 |
| YTD | 31-Dec-24 | 11005.00 | 10.05% | - | 47/201 |
| 1 Year | 04-Nov-24 | 10990.80 | 9.91% | 9.91% | 44/187 |
| 2 Year | 03-Nov-23 | 13899.10 | 38.99% | 17.84% | 94/141 |
| 3 Year | 04-Nov-22 | 17089.10 | 70.89% | 19.54% | 57/117 |
| 5 Year | 04-Nov-20 | 20694.10 | 106.94% | 15.65% | 84/93 |
| 10 Year | 04-Nov-15 | 41388.30 | 313.88% | 15.25% | 37/65 |
| Since Inception | 02-Jan-13 | 69444.90 | 594.45% | 16.28% | 107/223 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 04-Nov-24 | 12000 | 13141.44 | 9.51 % | 18.02 % |
| 2 Year | 03-Nov-23 | 24000 | 27669.49 | 15.29 % | 14.3 % |
| 3 Year | 04-Nov-22 | 36000 | 45096 | 25.27 % | 15.16 % |
| 5 Year | 04-Nov-20 | 60000 | 84829.65 | 41.38 % | 13.81 % |
| 10 Year | 04-Nov-15 | 120000 | 271660.54 | 126.38 % | 15.59 % |
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Alphabet Inc - Class C | Foreign equity | 994.3 | 2.97% | 0.40% | 2.97% (Sep 2025) | 1.71% (Nov 2024) | 45.98 k | 0.00 |
| Huntington Ingalls Industries Inc | Foreign equity | 988.8 | 2.96% | 0.22% | 3.64% (Apr 2025) | 1.72% (Oct 2024) | 38.68 k | 0.00 |
| West Pharmaceutical Services Inc | Foreign equity | 946.6 | 2.83% | -0.02% | 2.98% (Mar 2025) | 0% (Oct 2024) | 40.64 k | -3.46 k |
| Estee Lauder CL | Foreign equity | 902.7 | 2.70% | -0.07% | 2.89% (Jul 2025) | 1.92% (Oct 2024) | 1.15 L | 0.00 |
| Agilent Technologies Inc | Foreign equity | 863 | 2.58% | 0.09% | 2.58% (Sep 2025) | 2.07% (Mar 2025) | 75.73 k | 0.00 |
| US Bancorp | Foreign equity | 832.6 | 2.49% | 0.01% | 2.61% (Nov 2024) | 2.28% (Apr 2025) | 1.94 L | 0.00 |
| Zimmer Biomet Holdings Inc. | Foreign equity | 822.1 | 2.46% | -0.15% | 2.73% (Mar 2025) | 2.32% (Jul 2025) | 94.00 k | 0.00 |
| Pfizer Inc | Foreign equity | 821.2 | 2.46% | 0.10% | 2.59% (Apr 2025) | 2.24% (Nov 2024) | 3.63 L | 0.00 |
| Nike Inc | Foreign equity | 802.3 | 2.40% | -0.22% | 2.62% (Aug 2025) | 2.01% (Mar 2025) | 1.30 L | 0.00 |
| GE Healthcare Technologies Inc. | Foreign equity | 801.5 | 2.40% | 0.08% | 2.45% (Jun 2025) | 0% (Oct 2024) | 1.20 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| Net Receivables | Net Receivables | 2.30% |
| TREPS | TREPS | 0.10% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
Out of 0 mutual fund schemes offered by this AMC, and 0 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| No Data Found |